What life can do

Accelerate your product innovation with microbial biotechnology solutions

Strain

Engineering

Microbiome

Deciphering

Bioprocess

Development

Transfer at

Industrial Scale

Tailor-made industrial biosolutions

Tailor-made industrial biosolutions

Abolis is a specialized biotech partner offering end-to-end solutions for bio-based product innovation.

We support a wide range of applications, with functional ingredients, and bio-based chemicals, using advanced microbial engineering and fermentation technologies.

Our deep expertise in synthetic biology, microbial ecosystems, robust process development, and scalable platforms empower biotech and industrial partners to accelerate innovation with sustainability and precision.

Product InnovationProduct
Innovation
Supply Chain SecurizationSupply Chain
Securization
Manufacturing Costs ReductionManufacturing
Costs Reduction
Sustainable ProductionSustainable
Production

Applications

Applications

We support a wide range of industries

+0
peopleon two sites
0
yearsof existence
+0K
sqmof labs
+0
customersWorldwide

Trusted Partners

Trusted Partners

htba
loreal
evonik
byorna
europai
danone
htba
loreal
evonik
byorna
europai
danone

News

News

Release

Natural beauty ingredients get biotech rebuild as crop scarcity rises

Beauty brands are turning to biotechnology to produce natural ingredients with greater consistency, traceability, and supply security

Release

Abolis Biotechnologies brings French industrial biotech excellence to Saudi Arabia

Abolis Biotechnologies brings French industrial biotech excellence to Saudi Arabia, driving the Kingdom’s shift toward a sustainable and sovereign bioeconomy - a momentum reinforced by its participation in the Booster Grow Global KSA program.

Release

Abolis Biotechnologies and EUROAPI enter into partnership to accelerate pharmaceutical innovation and restore European sovereignty

As part of the « Important Project of Common European Interest » (IPCEI) in the field of healthcare, the Med4Cure program includes public support of up to €140 million under France 2030.